期刊文献+

大肠癌p53、K-ras基因突变研究 被引量:1

Study of p53 and K-ras gene mutation in colorectal carcinoma by PCR-SSCP
下载PDF
导出
摘要 目的探讨p53、K-ras基因突变与大肠癌发生、发展的关系.方法应用PCR-SSCP方法研究68例大肠癌和癌旁组织以及20例正常组织p53、K-ras基因突变情况.结果大肠癌组中p53、K-ras基因突变率分别为47.1%和44.1%,明显高于癌旁组(分别为13.2%和7.4%).20例正常组织中未检出p53、K-ras基因突变.大肠癌伴有淋巴结转移及远处转移者。p53、K-ras基因突变率明显高于无淋巴结及远处转移者;p53、K-ras基因突变与组织学分型无关.结论 p53、K-ras基因突变与大肠癌发生、发展有密切关系,在细胞癌变中起重要作用,可作为评估大肠癌转移的分子生物学指标. Objective To study the relation between p53, K-ras gene mutation and the occurrence and development of colorectal carcinoma. Methods The positive rate of p53 and K-ras gene mutation in 68 cases cancer tissue, tissue sampces adjacent to tumors and 20 normal controls were studied by PCR-SSCP. Results The positive rate of p53 and K-ras gene mutation in cancer tissue (47.1%, 32/68; 44.1%. 30/68) were significantly higher than in tissue adjacent to tumur, (13.2%. 9/68; 7.4%. 5/68). p53, K-ras gene mutation were not detected in 20 normal tissue. The positivity of p53 and K-ras gene mutation in the group with lymph nodes and distant metastasis was markedly higher than those in the group without metastasis, but their relation to the histologic types was not significant Conclusions A close correlation was present between p53, K-ras gene mutation and the occurrence and development of colorectal carcinoma. p53 and K-ras gene mutation in cancer tissue may play an important role during colorectal carcinogenesis, and could be regarded as biomolecular index for the evaluation of metastasis in colorectal carcinoma.
出处 《现代消化及介入诊疗》 2002年第2期30-32,共3页 Modern Interventional Diagnosis and Treatment in Gastroenterology
关键词 PCR-SSCP 大肠癌 P53 K-RAS 基因突变 PCR-SSCP colorectal carcinoma p53 K-ras gene mutation
  • 相关文献

同被引文献17

  • 1周坤,葛海燕.腹腔镜结直肠癌根治术对肿瘤细胞微转移影响的研究[J].中国普通外科杂志,2005,14(12):896-899. 被引量:5
  • 2Zshida H,Murata N,Tada M,et al.Determining the levels matrix metalloproteinase-9 in portal and peripheral blood is useful for predicting liver metastasis of colorectal cancer[J].Jpn J Clin Oncol,2003,33 (4):186-191.
  • 3Zucker S,Lysik RM,Dimassimo BI,et al.Plasma assay of gelatinase B:tissue inhibitor of metalloproteina complexes in cancer[J].Cancer,1995,76(4):700 -708.
  • 4Lee JC,Chow NM,Wang ST,et al.Prognostic value of vascular endothelial growth factor expression in colorectal cancer patients[J].Eur J Cancer,2000,36 (6):748-753.
  • 5Yamaguchi A,Nakagawara G,Kurosaka Y,et al.p53 immunoreaction in endoscopic biopsy specimens of colorectal cancer,and its prognostic significance[J].Br J Cancer,1993,68(2):399 -402.
  • 6Nystrom Lahti M,Wu Y,Moisio AL.DNA mismatch repair gene mutation in 55 kindreds with verified or putative hereditary non-polyposis colorectal cancer[J].Hum Mol Genet,1996,5(6):763 -769.
  • 7Baldwin AS Jr.The NF-κB,IκB proteins new discoveries and insights[J].Annu Rev lmmunol,1996,14(2):649 -683.
  • 8高鹏,吴爱国,王宇,杨继震.大肠癌组织微血管密度和血管内皮生长因子表达的研究[J].中华实验外科杂志,2000,17(4):306-307. 被引量:7
  • 9范伟,薛敏,等.大肠癌中myc基因表达的研究[J].中华医学全科杂志,2003,2(2):18-19. 被引量:1
  • 10陈子华,冯斌.NM_(23)、VEGF蛋白表达与大肠癌肝转移的关系及其意义[J].中国现代医学杂志,2003,13(11):20-22. 被引量:5

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部